T cell therapy, which uses a patient's own immune cells to fight cancer, has emerged as a powerful way to treat lymphoma and other blood cancers. But researchers have struggled to adapt the treatment ...

U of A Comprehensive Cancer Center Director Dr. Dan Theodorescu plans to study loss of Y chromosome biology and investigate ...

In vivo CAR T-cell therapies could improve access by eliminating complex logistics and reducing costs, making them more accessible to underserved populations. Traditional CAR T-cell therapies face ...

CAR T-cell therapy has the potential to revolutionise how we treat certain types of cancer by genetically engineering someone’s own immune cells to attack the disease – but it is also cumbersome and ...

Philadelphia’s pioneering cancer scientist, Carl June, has been honored with two awards in the last month for his seminal work engineering the body’s immune system to fight cancer. June has spent ...

Researchers at MIT and Harvard have developed CAR-NK cells, which could lead to more effective cancer treatment.

Read full article: Early voting begins in Central Florida special elections after sample-ballot debacle Read full article: 140 in a 70: ‘Super speeder’ arrested in Orlando told deputy he was late for ...

One of the newest weapons that scientists have developed against cancer is a type of engineered immune cell known as CAR-NK ...

University of Arizona Cancer Center researchers will study the potential effects of the loss of the Y chromosome in the ...

Enabling patients to generate CAR T-cells internally could cut kidney cancer therapy costs, explained Dr. Wayne Marasco of Dana-Farber Cancer Institute. In vivo CAR T-cell therapy could drastically ...

CAR T-cell therapy shows promise for SCLC, but significant barriers, such as tumor heterogeneity and immunosuppression, must be addressed. Early research has identified several antigens that could ...